Sr-Model 230 (Modification)
by Hirata Sangyo Co. USA, Inc.
510(k) K864106
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK864106 | Date19 Nov 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FRN
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5725
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
This device is an infusion pump, classified under medical specialty General Hospital. It is a pump designed for the delivery of fluids in a controlled manner.
It was cleared via the FDA 510(k) process under K864106 with a substantially equivalent decision on 1986-11-19. The device is classified as Class II, product code FRN, and regulation number 880.5725. It was not third-party reviewed.
Other devices from Hirata Sangyo Co. USA, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the SR-MODEL 230 (MODIFICATION) infusion pump used for?
The SR-MODEL 230 (MODIFICATION) is designed for the delivery of fluids in a controlled manner, as specified in its FDA 510(k) clearance. It is intended for use in general hospital settings where precise fluid administration is required, such as intravenous therapy or medication infusion, based on its classification under product code FRN and regulation number 880.5725.
How was the SR-MODEL 230 (MODIFICATION) cleared for market release?
The device was cleared through the FDA’s traditional 510(k) process under submission K864106, receiving a substantially equivalent decision on November 19, 1986. This means it was found to be substantially equivalent to a legally marketed predicate device, allowing it to be marketed without requiring a premarket approval application.
Is the SR-MODEL 230 (MODIFICATION) a single-use or reusable device?
The provided device data does not specify whether the SR-MODEL 230 (MODIFICATION) is intended for single-use or reuse. Information regarding sterility, reusability, or reprocessing instructions is not included in the authorization or specification fields. Users should consult the manufacturer’s labeling for detailed guidance on intended use and handling.
What regulatory classification applies to the SR-MODEL 230 (MODIFICATION)?
The SR-MODEL 230 (MODIFICATION) is classified as a Class II medical device under FDA regulations, with product code FRN and regulation number 880.5725. This classification indicates it poses moderate risk and is subject to special controls to ensure safety and effectiveness, as determined by its 510(k) clearance.
Who manufactures the SR-MODEL 230 (MODIFICATION) and where is it registered?
The SR-MODEL 230 (MODIFICATION) is manufactured by Hirata Sangyo Co. USA, Inc., located at 810 S. Spring St., Suite 404, Los Angeles, CA 90014. The device’s establishment registration and device listing information are associated with this address, as reflected in the OpenFDA fields and registration number data provided in the device record.